Electrophysiological correlates of reduced pain perception after theta-burst stimulation

In an earlier study, we reported the antinociceptive effects of a special repetitive transcranial magnetic stimulation paradigm: continuous theta-burst stimulation (cTBS), when applied to human motor cortex. Here, we investigated whether the reduced subjective pain perception of 10 healthy individuals could be measured by changes in laser-evoked potentials, a reflection of pain related activations in the operculoinsular and midcingulate cortex. To minimize the effect of habituation during repeated laser stimulation, a bioadaptive design was used. However, both pain ratings and laser-evoked potential amplitudes were reduced after real and sham cTBS. When compared with sham stimulation, cTBS resulted in a significantly greater diminution of pain ratings and N2–P2 amplitudes on the hand contralateral to the site of motor cortex stimulation.

[1]  M Lotze,et al.  The brain of opera singers: experience-dependent changes in functional activation. , 2010, Cerebral cortex.

[2]  Mark Jenkinson,et al.  Combining shape and connectivity analysis: An MRI study of thalamic degeneration in Alzheimer's disease , 2010, NeuroImage.

[3]  R. Veit,et al.  The truth about lying: inhibition of the anterior prefrontal cortex improves deceptive behavior. , 2010, Cerebral cortex.

[4]  P. Vermersch,et al.  Demographic and clinic characteristics of French patients treated with natalizumab in clinical practice , 2010, Journal of Neurology.

[5]  R. Liblau,et al.  Cell-cell cooperation at the T helper cell/mast cell immunological synapse. , 2009, Blood.

[6]  M. Rovaris,et al.  A reassessment of the plateauing relationship between T2 lesion load and disability in MS , 2009, Neurology.

[7]  J. Schoenen,et al.  Glossopharyngeal Neuralgia Triggered by Non-Noxious Stimuli at Multiple Cephalic and Extracephalic Sites , 2009, Cephalalgia : an international journal of headache.

[8]  H. Diener,et al.  Tonabersat, a Gap-Junction Modulator: Efficacy and Safety in Two Randomized, Placebo-Controlled, Dose-Ranging Studies of Acute Migraineceph , 2009, Cephalalgia : an international journal of headache.

[9]  David H. Miller,et al.  Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial , 2009, The Lancet Neurology.

[10]  N. Birbaumer,et al.  The insulin effect on cerebrocortical theta activity is associated with serum concentrations of saturated nonesterified Fatty acids. , 2009, The Journal of clinical endocrinology and metabolism.

[11]  Niels Birbaumer,et al.  Hemodynamic brain-computer interfaces for communication and rehabilitation , 2009, Neural Networks.

[12]  W. M. van der Flier,et al.  Patients With Alzheimer Disease With Multiple Microbleeds: Relation With Cerebrospinal Fluid Biomarkers and Cognition , 2009, Stroke.

[13]  R. Lipton,et al.  Migraine and cardiovascular disease: systematic review and meta-analysis , 2009, BMJ : British Medical Journal.

[14]  M. Filippi,et al.  Primary progressive multiple sclerosis: tactile-associated functional MR activity in the cervical spinal cord. , 2009, Radiology.

[15]  W. M. van der Flier,et al.  Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. , 2009, Radiology.

[16]  M. Filippi,et al.  250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study , 2009, The Lancet Neurology.

[17]  Nick C Fox,et al.  Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease , 2009, Neurology.

[18]  Falk Eippert,et al.  When seeing outweighs feeling: a role for prefrontal cortex in passive control of negative affect in blindsight , 2009 .

[19]  C. Sindic,et al.  A Subacute Behavioral Disorder In a Female Adolescent. Autoimmune Anti-N-methyl-D-aspartate Receptor Encephalitis Associated with Ovarian Teratoma , 2009, Biological Psychiatry.

[20]  M. Filippi,et al.  Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients? , 2009, Human brain mapping.

[21]  Massimo Filippi,et al.  Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. , 2009, Archives of neurology.

[22]  J. Buring,et al.  Migraine frequency and risk of cardiovascular disease in women , 2009, Neurology.

[23]  Marco Rovaris,et al.  Corpus callosum damage and cognitive dysfunction in benign MS , 2009, Human brain mapping.

[24]  J. Schoenen,et al.  Implementation and evaluation of existing guidelines on the use of neurophysiological tests in non‐acute migraine patients: a questionnaire survey of neurologists and primary care physicians , 2009, European journal of neurology.

[25]  Nick C. Fox,et al.  Accelerating regional atrophy rates in the progression from normal aging to Alzheimer’s disease , 2009, European Radiology.

[26]  Frederik Barkhof,et al.  Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort , 2009, BMJ : British Medical Journal.

[27]  G. Coppola,et al.  Nitroglycerin sensitises in healthy subjects CNS structures involved in migraine pathophysiology: Evidence from a study of nociceptive blink reflexes and visual evoked potentials , 2009, PAIN®.

[28]  P. Scheltens,et al.  White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[29]  C. Godfraind,et al.  Diagnostic and therapeutic pitfalls in neurosarcoidosis. , 2009, Acta neurologica Belgica.

[30]  G. Krishnamoorthy,et al.  Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis , 2009, Nature Medicine.

[31]  David H. Miller,et al.  Imaging outcomes for neuroprotection and repair in multiple sclerosis trials , 2009, Nature Reviews Neurology.

[32]  C. Sindic,et al.  Expression of Human Amyloid Precursor Protein in Rat Cortical Neurons Inhibits Calcium Oscillations , 2009, The Journal of Neuroscience.

[33]  R. Liblau,et al.  Invariant NKT cells inhibit development of the Th17 lineage , 2009, Proceedings of the National Academy of Sciences.

[34]  M. Freedman,et al.  Anti-α-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event , 2009, Multiple sclerosis.

[35]  J. Palace,et al.  Immunocapture and Identification of Cell Membrane Protein Antigenic Targets of Serum Autoantibodies* , 2009, Molecular & Cellular Proteomics.

[36]  I. Arisi,et al.  The interplay of two single nucleotide polymorphisms in the CACNA1A gene may contribute to migraine susceptibility , 2009, Neuroscience Letters.

[37]  L. Boron,et al.  Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis , 2009, Multiple sclerosis.

[38]  Shibeshih Belachew,et al.  Cell “circadian” cycle: New role for mammalian core clock genes , 2009, Cell cycle.

[39]  T. Kurth,et al.  ACE D/I polymorphism, migraine, and cardiovascular disease in women , 2009, Neurology.

[40]  L. Nguyen,et al.  Elongator Controls the Migration and Differentiation of Cortical Neurons through Acetylation of α-Tubulin , 2009, Cell.

[41]  L. Nguyen,et al.  Adult neurogenesis and the diseased brain. , 2009, Current medicinal chemistry.

[42]  X. Noël,et al.  Impaired inhibition of proactive interference in abstinent individuals with alcoholism , 2009, Journal of clinical and experimental neuropsychology.

[43]  H. Diener,et al.  Migraine and risk of cardiovascular disease in women , 2009, Neurology.

[44]  N. Barbaro,et al.  21 Motor Cortex Stimulation for Central and Neuropathic Pain , 2009 .

[45]  Niels Birbaumer,et al.  Neurofeedback and brain-computer interface clinical applications. , 2009, International review of neurobiology.

[46]  P. Verbanck,et al.  Are patients with chronic fatigue syndrome just ‘tired’ or also ‘sleepy’? , 2008, Journal of sleep research.

[47]  A. Vincent,et al.  Antibody to aquaporin-4 in the long-term course of neuromyelitis optica , 2008, Brain : a journal of neurology.

[48]  Michael K. Hutchinson,et al.  PROGRESSIVE ENCEPHALOMYELITIS, RIGIDITY, AND MYOCLONUS: A NOVEL GLYCINE RECEPTOR ANTIBODY , 2008, Neurology.

[49]  Bengt Linderoth,et al.  Cholinergic mechanisms involved in the pain relieving effect of spinal cord stimulation in a model of neuropathy , 2008, PAIN.

[50]  M. Manns,et al.  Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. , 2008, Gastroenterology.

[51]  J. Buring,et al.  Migraine, vascular risk, and cardiovascular events in women: prospective cohort study , 2008, BMJ : British Medical Journal.

[52]  R. Liblau,et al.  Regulatory T cells in the control of inflammatory demyelinating diseases of the central nervous system , 2008, Current opinion in neurology.

[53]  P. Verbanck,et al.  Successful Treatment of Delusional Disorder of the Somatic Type or “Delusional Parasitosis” with Olanzapine , 2008, Pharmacopsychiatry.

[54]  R. Moriggl,et al.  Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens1 , 2008, The Journal of Immunology.

[55]  François Mauguière,et al.  Parallel Processing of Nociceptive A-δ Inputs in SII and Midcingulate Cortex in Humans , 2008, The Journal of Neuroscience.

[56]  A. Antal,et al.  Theta burst stimulation of the motor cortex reduces laser-evoked pain perception , 2008, Neuroreport.

[57]  J. Davoust,et al.  Antigen-Driven Interactions with Dendritic Cells and Expansion of Foxp3+ Regulatory T Cells Occur in the Absence of Inflammatory Signals1 , 2008, The Journal of Immunology.

[58]  Rolf-Detlef Treede,et al.  Peripheral and central components of habituation of heat pain perception and evoked potentials in humans , 2007, PAIN.

[59]  A. Antal,et al.  Attenuation of N2 amplitude of laser-evoked potentials by theta burst stimulation of primary somatosensory cortex , 2007, Experimental Brain Research.

[60]  R. Liblau,et al.  An antigen-specific pathway for CD8 T cells across the blood-brain barrier , 2007, The Journal of experimental medicine.

[61]  R. Liblau,et al.  Multimerized T cell epitopes protect from experimental autoimmune diabetes by inducing dominant tolerance , 2007, Proceedings of the National Academy of Sciences.

[62]  R. Liblau,et al.  Immune tolerance and control of CNS autoimmunity: from animal models to MS patients , 2007, Journal of neurochemistry.

[63]  S. Kaufmann,et al.  Ito cells are liver-resident antigen-presenting cells for activating T cell responses. , 2007, Immunity.

[64]  A. Gruber,et al.  Autoimmune-mediated intestinal inflammation-impact and regulation of antigen-specific CD8+ T cells. , 2006, Gastroenterology.

[65]  R. Liblau,et al.  Pertussis Toxin Reduces the Number of Splenic Foxp3+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[66]  C. Bodemer,et al.  Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells. , 2006, Blood.

[67]  B. Kyewski,et al.  Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[68]  D. Klatzmann,et al.  Therapeutic potential of self‐antigen‐specific CD4+CD25+ regulatory T cells selected in vitro from a polyclonal repertoire , 2006, European journal of immunology.

[69]  G. Coppola,et al.  Induction of Long-Lasting Changes of Visual Cortex Excitability by Five Daily Sessions of Repetitive Transcranial Magnetic Stimulation (rTMS) in Healthy Volunteers and Migraine Patients , 2006, Cephalalgia : an international journal of headache.

[70]  R. Liblau,et al.  LF 15-0195 Treatment Protects against Central Nervous System Autoimmunity by Favoring the Development of Foxp3-Expressing Regulatory CD4 T Cells1 , 2006, The Journal of Immunology.

[71]  J. Rothwell,et al.  Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[72]  J. Rothwell,et al.  Theta Burst Stimulation of the Human Motor Cortex , 2005, Neuron.

[73]  田村 洋平,et al.  Effects of 1-Hz repetitive transcranial magnetic stimulation on acute pain induced by capsaicin , 2005 .

[74]  R. Kakigi,et al.  Facilitation of Aδ-fiber-mediated acute pain by repetitive transcranial magnetic stimulation , 2004, Neurology.

[75]  John C Rothwell,et al.  The effect of short-duration bursts of high-frequency, low-intensity transcranial magnetic stimulation on the human motor cortex , 2004, Clinical Neurophysiology.

[76]  J. Lefaucheur,et al.  Neurogenic pain relief by repetitive transcranial magnetic cortical stimulation depends on the origin and the site of pain , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[77]  R Kakigi,et al.  Facilitation of A[delta]-fiber-mediated acute pain by repetitive transcranial magnetic stimulation. , 2004, Neurology.

[78]  M. Frot,et al.  Brain generators of laser-evoked potentials: from dipoles to functional significance , 2003, Neurophysiologie Clinique/Clinical Neurophysiology.

[79]  U. Baumgärtner,et al.  Clinical usefulness of laser-evoked potentials , 2003, Neurophysiologie Clinique/Clinical Neurophysiology.

[80]  Walter Magerl,et al.  Left-hemisphere dominance in early nociceptive processing in the human parasylvian cortex , 2003, NeuroImage.

[81]  N. Barbaro,et al.  Motor cortex stimulation for central and neuropathic pain: current status , 2003, Pain.

[82]  A. Kossev,et al.  Repetitive magnetic stimulation for the treatment of chronic pain conditions. , 2003, Supplements to Clinical neurophysiology.

[83]  J. Lefaucheur,et al.  Pain relief induced by repetitive transcranial magnetic stimulation of precentral cortex , 2001, Neuroreport.

[84]  J. Lefaucheur,et al.  Interventional neurophysiology for pain control: duration of pain relief following repetitive transcranial magnetic stimulation of the motor cortex , 2001, Neurophysiologie Clinique/Clinical Neurophysiology.

[85]  P Mertens,et al.  Electrical stimulation of motor cortex for pain control: a combined PET-scan and electrophysiological study , 1999, PAIN.

[86]  T. Yamamoto,et al.  Poststroke pain control by chronic motor cortex stimulation: neurological characteristics predicting a favorable response. , 1998, Journal of neurosurgery.

[87]  F. Mauguière,et al.  Association and dissociation between laser‐evoked potentials and pain perception , 1997, Neuroreport.

[88]  Thomas Weiss,et al.  A bioadaptive approach for experimental pain research in humans using laser-evoked brain potentials , 1997, Neuroscience Letters.

[89]  K. Arita,et al.  Transcranial magnetic coil stimulation of motor cortex in patients with central pain. , 1995, Neurosurgery.

[90]  G. V. Van Hoesen,et al.  Cingulate input to the primary and supplementary motor cortices in the rhesus monkey: Evidence for somatotopy in areas 24c and 23c , 1992, The Journal of comparative neurology.

[91]  A. Carmon,et al.  Peripheral fiber correlates to noxious thermal stimulation in humans , 1980, Neuroscience Letters.

[92]  C. Rose,et al.  Institut National de la Santé et de la Recherche Médicale , 1976 .

[93]  M. Uslenghi,et al.  The World Space Observatory (WSO-UV) - Current status , 2008, 0801.2080.